<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Kişiselleştirilmiş Kanser İmmünoterapisi &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/kisisellestirilmis-kanser-immunoterapisi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Jan 2026 19:38:10 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.4</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Kişiselleştirilmiş Kanser İmmünoterapisi &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Tracking T Cell Changes in Melanoma Treatment</title>
		<link>https://bioengineer.org/tracking-t-cell-changes-in-melanoma-treatment/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 19 Jan 2026 19:37:44 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[adaptif hücre transferi]]></category>
		<category><![CDATA[Adoptif Hücre Transferi (ACT)]]></category>
		<category><![CDATA[genomik sekanslama** **Açıklama:** 1. **melanoma immünoterapisi:** Makalenin temel konusu olan melanoma tedavisinde kullanılan imm]]></category>
		<category><![CDATA[İleri Melanoma Tedavisi]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **melanoma immünoterapisi]]></category>
		<category><![CDATA[Kişiselleştirilmiş Kanser İmmünoterapisi]]></category>
		<category><![CDATA[kişiselleştirilmiş kanser tedavisi]]></category>
		<category><![CDATA[T hücresi repertoarı]]></category>
		<category><![CDATA[T Hücresi Tükenmesi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/tracking-t-cell-changes-in-melanoma-treatment/</guid>

					<description><![CDATA[In a groundbreaking study set to reshape the landscape of immunotherapy for advanced melanoma, a team of researchers led by Kerr, C., Soleimani, S., and Mulder, D.T., has delved into the intricate world of T cell repertoire dynamics within the context of adoptive cell transfer (ACT). This promising technique involves harnessing the power of the [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">318523</post-id>	</item>
	</channel>
</rss>
